GlassScriptPhysician profile
Nathan Michael Litton
NPI 1639680523
$1,474.33
in general payments reported to CMS, 2019-2025
23 companies · $1,007 in 2025
The $1,007 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.41 · 2023: $180 · 2024: $239 · 2025: $1,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,426.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $203.31 | 2025 | Airsupra, Nexium |
| Abbvie INC. | $172.82 | 2025 | |
| Novo Nordisk INC | $167.16 | 2025 | Ozempic, Wegovy |
| Inspire Medical Systems, INC. | $161.10 | 2023-2024 | Inspire |
| Idorsia Pharmaceuticals US INC | $133.87 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $86.33 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $67.87 | 2023-2025 | Arexvy, Shingrix |
| Sanofi Pasteur INC. | $58.53 | 2022-2025 | |
| Astellas Pharma US INC | $44.41 | 2025 | Veozah |
| Pfizer INC. | $41.04 | 2025 | |
| Hologic Sales and Service, LLC | $38.56 | 2025 | Thinprep 2000 Processor, Aptima |
| Lilly USA, LLC | $36.69 | 2024-2025 | Mounjaro, Zepbound |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $34.67 | 2025 | Caplyta |
| Amgen INC. | $33.60 | 2025 | Krystexxa |
| Abbott Laboratories | $33.47 | 2022-2025 | Id Now Instrument |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $25.92 | 2025 | Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $23.72 | 2025 | |
| Seqirus USA INC | $22.08 | 2025 | Fluad, Flucelvax |
| Edwards Lifesciences Corporation | $21.32 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $18.04 | 2025 | Vaxneuvance, Enflonsia, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $17.73 | 2024 | |
| Philips North America LLC | $16.14 | 2024 | (Ck7) Extended Holter |
| Viiv Healthcare Company | $15.95 | 2024 | Apretude |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Litton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.